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ABSTRACT  23 
Using the 20-meter shuttle run test (20mSRT) as a morbidity metric, we assessed if 24 
Schistosoma mansoni infection was associated with decreased aerobic capacity in Ugandan 25 
children across a range of altitudes, either at low (~600m) or high (~1000m) altitudes. A total 26 
of 305 children were recruited from six schools within the Buliisa district, Lake Albert, 27 
Uganda. A subset (n=96) of these had been previously assessed and treated for 28 
schistosomiasis +/- malaria two weeks prior. Fitness scores on the 20mSRT were translated 29 
into VO2max using a standardised equation. Unadjusted and multivariable-adjusted 30 
analyses were performed using VO2max as the primary outcome. 31 
Analysis of fitness scores from 304 children, inclusive of the subset follow-up cohort, 32 
revealed a median VO2max of 45.4 mL kg-1 min-1 (IQR 42.9 - 48.0 mL kg-1 min-1). Children 33 
residing at high altitudes demonstrated increased aerobic capacities (46.3 vs 44.8 mLkg-1 34 
min-1, P = 0.031). The prevalence of stunting, wasting, S. mansoni egg patent infection, 35 
malaria, giardiasis, anemia and fecal occult blood were 36.7%, 16.1%, 44.3%, 65.2%, 36 
21.4%, 50.6%, and 41.2%, respectively. Median VO2max was elevated in those previously 37 
treated, compared with those newly recruited (46.3 mL kg-1 min-1 vs 44 mL kg-1 min-1, P < 38 
0.001). Multivariable-adjusted analysis revealed a strong negative association between S. 39 
mansoni egg patent infection and VO2max at low altitude (beta coefficient -3.96, 95% CI -40 
6.56, -1.37, P = 0.004). This is the first study to document a negative association between S. 41 
mansoni infection and aerobic capacity at low altitudes using the 20mSRT. 42 
 43 
 44 
 45 
 46 
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 49 
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INTRODUCTION  50 
 Intestinal schistosomiasis, as caused by infection with Schistosoma mansoni, is an 51 
important contributor towards chronic morbidity in African children as measured by various 52 
methodologies.1, 2, 3, 4, 5, 6, 7, 8, 9, 10 However, its impact upon diminished exercise tolerance is 53 
not well explored. By contrast, the functional consequence of Schistosoma haematobium-54 
associated anemia has been assessed by the 20m shuttle run test (20mSRT) and validated  55 
to provide an accurate correlate of aerobic capacity, the VO2max (measured in mL kg-1 min-56 
1).11 57 
 The pathophysiological pathway underlying decreased physical fitness in children with 58 
either form of schistosomiasis is complex, hinging  upon immuno-pathological lesions  and 59 
generalised inflammatory responses.12, 13, 14 Anemia is a cause of decreased oxygen carrying 60 
capacity and has been associated with both heavy and light Schistosoma infections in 61 
childhood.1, 2, 4, 9, 15, 16, 17, 18, 19, 20, 21, 22 The predominant underlying mechanism seems to be 62 
anemia of inflammation, involving pro-inflammatory cytokines including TNF-alpha and 63 
Interleukin-6.23, 24, 25 Other mechanisms include ulcerative passage of eggs through the 64 
intestinal wall causing extracorporeal blood loss, splenic sequestration and autoimmune 65 
hemolysis.17, 26, 27 66 
 Lake Albert in Western Uganda provides the optimum habitat for Biomphalaria snails, 67 
the intermediate host for S. mansoni, making it a hub for S. mansoni transmission. Previous 68 
studies have identified egg patent S. mansoni infection prevalences of up to 82% amongst 69 
children aged 5-10 years living in the region.28 Since 2004, the control of schistosomiasis-70 
related morbidity in Uganda has been centered upon the targeted, periodic distribution of 71 
praziquantel therapy to school-aged children aged over 4 years and selected ‘at risk’ adult 72 
populations,.29 Proxy markers of morbidity have since been evaluated, including faecal 73 
occult blood, anemia, and faecal calprotectin testing, quality of life questionnaires, biometry, 74 
clinical palpation and measurement, portable ultrasonography and fitness tests.12, 30, 31  75 
 Previous studies investigating the relationship of S. mansoni infection with physical 76 
fitness as measured by the 20mSRT have been inconclusive, limited by small sample sizes, 77 
Smith et al.                                                              S.mansoni and fitness in Ugandan children 
 
 4 
and have not compared or incorporated altitudinal effects.7, 8 Altitude acclimatization with an 78 
associated increase in red blood cell volume may occur at altitudes as low as ~1000m.32 79 
This study aimed to determine whether S. mansoni infection was associated with decreased 80 
aerobic capacity in Ugandan children living at low (~600m) or high (~1000m) altitudes. It was 81 
hypothesised that S. mansoni infection would correlate with decreased aerobic capacity in 82 
Ugandan children and that this association would be less pronounced in children living at 83 
high altitude. 84 
 85 
METHODS 86 
Ethics Statement & Eligibility Criteria 87 
Ethical approval was obtained from the London School of Hygiene & Tropical 88 
Medicine (LSHTM) Ethics Committee (LSHTM number 12034), Liverpool School of Tropical 89 
Medicine (LSTM) Masters Review Panel (M09-17), and the Vector Control Division, Ministry 90 
of Health, Uganda (VCDREC-082). Children were considered eligible for enrolment if they 91 
were aged 7-15 years, medically fit, had resided in a S. mansoni-endemic area for at least 92 
two years, and could provide child assent. 93 
 94 
Study Setting & Population 95 
This study was carried out in six S. mansoni-endemic schools within the Buliisa 96 
district of Lake Albert in Western Uganda: Biiso (latitude 41.4199, longitude 1.7606), 97 
Busingiro (latitude 31.4475, longitude 1.7354), Bugoigo Islamic (latitude 31.4122, longitude 98 
1.9000), Bugoigo Primary (latitude 31.4167, longitude 1.9089), Nyamukuta (latitude 31.4000, 99 
longitude 1.8683), and Walukuba (latitude 31.3831, longitude 1.8425). Epidemiological data 100 
previously collected within this region provided a useful foundation and thereby influenced 101 
the selection of schools for our study.28, 33, 34 Buliisa is bordered by Nebbi (north), Masindi 102 
(east), Hoima (south), and the Democratic Republic of Congo (west). Biiso and Busingiro lay 103 
at altitudes of 1004m and 1062m respectively. The remainder of the schools lay adjacent to 104 
Lake Albert with an altitude of 616m. The geographical proximities of the schools to the lake 105 
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shoreline are <1km for Bugoigo and Walukuba, and approximately 9km and 14km for Biiso, 106 
and Busingiro, respectively. Egg patent S. mansoni infection prevalences among children 107 
aged 5-10 years in the villages of Bugoigo, Walukuba, Biiso, and Busingiro have been 108 
previously identified to be 36.7%, 82.0%, 19.7% and 8.0% respectively.28 No transmission of 109 
Schistosoma haematobium has been documented on parasitological surveys in the field of 110 
study.28, 35 111 
The study involved 305 schoolchildren aged 7 to 15 years. Of the 305 schoolchildren, 112 
a total of 96 children from Biiso, Busingiro, and Bugoigo Islamic schools were followed up 113 
from two weeks prior. The team had performed an identical armoury of parasitological 114 
diagnostic tests, 20m-shuttle run testing, and had administered praziquantel, albendazole 115 
and, if malaria-positive, artemether-lumefantrine therapy.116 
The study team was comprised of members from LSHTM, LSTM and the Vector 117 
Control Division, Ministry of Health, Uganda. Subjects were enrolled following random 118 
selection from the P2 to P6 class registers of each school over a 9-day period in June 2017. 119 
For each village, community mobilisers assisted with community sensitisation prior to data 120 
collection. Three of the six schools sampled had been recently sensitised by the preceding 121 
LSTM team. Head teacher consent and written child assent were obtained. The information 122 
sheets were translated into the local Alur dialect and distributed. The rationale for the study 123 
was explained using a local translator.  124 
Forty to sixty children were sampled per day. The principal investigator, a qualified 125 
medical practitioner, assessed each child’s general health prior to study participation. Each 126 
child was assigned a unique study identification number which was written on a wristband to 127 
be worn by the child during testing. They were asked a brief series of questions related to 128 
their demographics, medical background, and previous praziquantel administration using 129 
LSHTM Open Data Kit software on a tablet device (http://opendatakit.lshtm.ac.uk/odk/). The 130 
frequency of mass drug administration with praziquantel at each school was recorded 131 
following head teacher questioning. 132 
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Anthropometric Assessment  133 
Assessment for stunting was performed using validated charts based on height-for-134 
age (HFA) Z-score: 'stunted' was defined as ≤ 2 to > 3 S.D. below the mean, and 'severely 135 
stunted' was defined as ≤ 3 S.D. below the mean.36 Calibrated measurements of weight and 136 
height were obtained by trained field workers using standardised scales and a standardised 137 
stadiometer, respectively. The height values obtained were for only a subset of the new 138 
participants and were converted to HFA Z-scores according to a standardised reference.37 139 
Body mass index (BMI) was calculated for each child for whom height and weight were 140 
obtained and converted to BMI-for-age (BFA) Z-scores according to a standardised 141 
reference.37 Results were recorded on the standardised data collection form. 142 
 143 
20-meter Shuttle Run Test  144 
Each participant undertook a 20-meter Shuttle Run Test (20mSRT).11 The test was 145 
performed in the school grounds on a clear and level playing field during school hours to 146 
maximise convenience and minimise disruption to the school day program. Six to twelve 147 
children were tested at any one time. For every four children, one observer was ascribed to 148 
ensure adequate monitoring of their performance. Careful instructions were given using a 149 
local translator and a brief demonstration of the test was performed by the principal 150 
investigator prior to testing. All children were kept well hydrated, and water and sugary 151 
snacks were made available. 152 
Materials used included two pre-measured 20-meter ropes, markers, a microphone, 153 
a portable speaker, and a tablet device with a relevant application for the 20mSRT (Bleep 154 
Fitness Test, Aspectica Ltd). Coloured bibs were worn by the study participants for ease of 155 
identification. Each fitness score was then translated into VO2max (mL kg -1 min-1) using a 156 
validated reference.11 157 
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Field-Based Parasitological Diagnostic Testing & Treatment 158 
 A single urine specimen was obtained from each child and tested for the presence of 159 
urine circulating cathodic antigen (urine-CCA; Rapid Medical Diagnostics, Pretoria, South 160 
Africa). Urine-CCA has the advantage of detecting light intensity infections which may be 161 
missed using the traditional Kato-Katz technique.38 The test band reaction intensity was 162 
semi-quantitatively graded as negative (-), trace positive (tr), single positive (+), double 163 
positive (++), and triple positive (+++). 164 
The presence of S. mansoni infection was determined by duplicate Kato-Katz thick 165 
fecal smears (each 41.7mg) prepared by trained field technicians in accordance with Katz et 166 
al.39 Kato-Katz examination indicates infection with mature, egg-shedding worms. The 167 
technique was employed to provide further information into the level of egg excretion, which 168 
is likely a proxy marker of bowel morbidity in addition to infection. Microscopy with a natural 169 
light source was used for in-field interpretation on the day of testing. S. mansoni egg counts 170 
and the number of eggs per gram (epg) of stool based upon the mean of the two specimens 171 
were documented. Each fecal specimen was tested for the presence of Giardia duodenalis 172 
infection using the Giardia/Cryptosporidium Quik Chek test (TECHLAB®, Inc.), and human 173 
hemoglobin and transferrin using the Transferrin/FOB Combo Rapid Test Cassette 174 
(Hangzhou AllTest Biotech co. Ltd.).  175 
Capillary blood sampling was used to determine the total hemoglobin level 176 
(HemoCue 201+, Angelholm, Sweden) and screen for malaria infection (Standard 177 
Diagnostics BIOLINE Malaria Ag P.f./Pan, Alere, TM.). Follow-up children were not screened 178 
for malaria, given the likelihood of persistent antigenemia following recent testing.  179 
Of the new participants, those who tested positive for schistosomiasis on urine-CCA 180 
and/or malaria were administered standardised therapy for schistosomiasis and/or malaria, 181 
respectively in keeping with national guidelines. All participants were administered 182 
albendazole therapy. Of the follow-up participants, only those who tested positive for urine-183 
CCA were administered praziquantel therapy, given their recent treatment by the preceding 184 
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team. No children were identified as being unwell or required referral to the local Level 2 185 
health care facility. 186 
 187 
Data Management & Statistical Analysis  188 
All data collected was de-identified, entered into Microsoft Excel (Version 16.13.1) or 189 
LSHTM Open Data Kit software, and stored on an encrypted USB device. Data analysis was 190 
performed using STATA 14.2 on those for whom 20mSRT data was obtained. Separate 191 
analyses of the entire cohort and of the follow-up participants were conducted. Descriptive 192 
analyses with stratifications by school and altitude (low: ~600m, high: ~1000m) were 193 
performed. Wilcoxan Rank Sum, Kruskall Wallis, Spearman’s correlation, Chi-squared tests, 194 
paired T test, and ANOVA were used to identify differences between schools and altitudes. 195 
Linear regression was employed to determine the unadjusted associations between 196 
independent covariates and the dependent variable, VO2max (continuous). Independent 197 
covariates of interest included egg patent S. mansoni infection (dichotomous), malaria 198 
infection (dichotomous), fecal occult blood (ordinal), anemia (dichotomous), stunting based 199 
on validated charts (dichotomous) and HFA Z-score ≤ 2 S.D. below the mean 200 
(dichotomous), and wasting defined by BFA Z-score ≤ 2 S.D. below the mean 201 
(dichotomous).29, 36, 37 Anemia was defined according to standardised cut-offs for age: < 202 
11.5g dL-1 (5 - 11y), < 12.0g dL-1 (12 - 14y) and adjusted for altitude using the equation ‘Hb 203 
(g dL-1) – 0.2g dL-1’  for an altitude approximating 1000m.40 Logistic regression was used to 204 
examine the unadjusted associations between the aforementioned covariates and 205 
dependent variables of fecal occult blood, anemia and stunting (by validated charts). 206 
Multivariable-adjusted linear regression was performed using VO2max as the dependent 207 
variable and multivariable-adjusted logistic regression analyses were undertaken using 208 
anemia, fecal occult blood and stunting each as the dependent variable. Model selection 209 
was performed using a stepwise procedure, followed by Akaike’s Information Criterion (AIC) 210 
as the model selection criterion. The model which minimised the AIC was selected. All 211 
analyses were stratified by gender and altitude. 212 
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 213 
RESULTS 214 
Participation 215 
Six schools within the Buliisa district were consecutively sampled: Biiso (n = 48), 216 
Busingiro (n = 46), Bugoigo Islamic (n = 48), Bugoigo Primary (n = 61), Nyamukuta (n = 61), 217 
and Walukuba (n = 40). Of the 305 children who participated, 304 completed the 20mSRT 218 
and were included within the final analysis. Only one child did not complete the 20mSRT due 219 
to a minor foot injury. Five children did not provide fecal samples and seven children did not 220 
provide urine for testing. Malaria, capillary hemoglobin, and fecal occult blood were limited 221 
by resource availability given the diversion of their use by the local clinic. Of 104 children 222 
sampled at baseline, 96 children completed the 20mSRT at follow-up (92.3%) and were 223 
included within the final analysis. The main reason for lack of follow-up was absence from 224 
school on the day of testing (Table 1). The remaining 208 children included within the final 225 
analysis were those newly recruited to the study.  226 
 227 
Descriptive Analyses 228 
The age, gender, and parasitology distributions were similar between schools, with 229 
the exception of malaria (P = 0.003, Table 1, Figure 1). The prevalence of S. mansoni may 230 
have been confounded by the variable distances of the schools from the lake. The 231 
prevalence of P. falciparum malaria was significantly higher at 1000m compared with 600m 232 
altitudes (P = 0.015, Table 2, Figure 1). Prevalence of S. mansoni by urine-CCA was highest 233 
(80.5%), followed by P. falciparum (65.2%), S. mansoni by egg patency (44.3%), and 234 
Giardia duodenalis infection (21.3%). All of the schools studied had received mass drug 235 
administration with praziquantel within the preceding twelve months. Overall, 34.5% of 236 
children were classified as anemic (n = 86/249) and 41.2% of children had fecal occult blood 237 
in the stool. There were no differences in prevalence of anemia or fecal occult blood and 238 
median hemoglobin between schools (Table 1). 239 
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 240 
Anthropometrics & Nutritional Status 241 
Acute and chronic malnutrition were identified within all schools. Overall, 36.7% of 242 
children were stunted according to a height-for-age Z-score ≤ 2 S.D. below the mean (n = 243 
79/215) and 16.7% were stunted according to validated charts (n = 49/293). Of the latter, 1% 244 
were severely stunted based on a height-for-age score ≤3 S.D. below the mean (n = 3/293, 245 
Table 1). 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
 254 
Figure 1: (A) Prevalence of egg patent S. mansoni infection according to school and altitude. 255 
(B) Prevalence of malaria infection according to altitude.  256 
 257 
Performance in the 20mSRT 258 
Careful instructions and a test demonstration were provided prior to shuttle run 259 
testing. Overall, the 20mSRT was well understood with very few false starts and trips 260 
observed. If either occurred, a rest period was provided and testing was recommenced. 261 
Overall, median VO2max was 45.4 mL kg-1 min-1 (IQR 42.9 – 48 mL kg-1 min-1) with higher 262 
values obtained by males compared with females (47.5 mL kg-1 min-1 vs 43.9 mL kg-1 min-1, 263 
P < 0.001, Table 1). Those children living at high altitude demonstrated a higher median 264 
VO2max compared with those residing at low altitude (46.3 mL kg-1 min-1 vs 44.8 mL kg-1 265 
min-1, P = 0.031, S1 Table). 266 
(A)                                                                  (B) 
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 When compared with a Canadian cohort, males demonstrated lower VO2max for all 267 
ages.11 Females demonstrated a lower VO2max up until the age of 12 years, after which an 268 
upward trend was observed. Figure 2 illustrates the differences between the Canadian and 269 
study cohorts by age and gender, and incorporates data from a Kenyan cohort for 270 
comparison.2 Outliers at the ages of 7 years (n = 3) and 15 years (n = 3) were excluded (S3 271 
Table). 272 
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TABLE 1: Demographic, Hematologic, Immunochemical, Parasitological & 20m-Shuttle Run Test Findings in Villages of the Buliisa District. 
Parameter 
Total  
(n = 304) 
Biiso  
(n = 48) 
Bugoigo Islamic  
(n = 48) 
Bugoigo Primary  
(n = 61) 
Busingiro  
(n = 46) 
Nyamukuta  
(n = 61) 
Walukuba  
(n = 40) 
P 
Value* 
DEMOGRAPHY 
Median age in years 
(interquartile range) 
11 (10-12.5) 11.5 (10-12.5) 11 (9-12) 11 (10-13) 11 (9-12) 10 (10-12) 12 (10-13) 0.091 
% Female (n) 49.7 (151/304) 50.0 (24/48) 50.0 (24/48) 49.2 (30/61) 47.8 (22/46) 50.8 (31/61) 50.0 (20/40) 1.000 
ANTHROPOMETRY 
Median height in 
centimeters  
(interquartile range) 
134 
(128.5-140.5) 
130.5 
(126.4-137.5) 
133.5 
(127.7-142.2) 
135.2 
(127.6-141.7) 
134 
(129.6-139) 
136 
(131.0-139.5) 
140.5 
(131.1-145.2) 
0.186 
% Stunted by HFA Z-
score (n)** 
36.7 (79/215) 41.2 (14/34) 51.4 (19/37) 43.2 (19/44) 17.2 (5/29) 29.4 (15/51) 35.0 (7/20) 0.064 
% Stunted by validated 
charts (n)*** 
16.7 (49/293) 20.8 (10/48) 20.5 (9/44) 17.2 (10/58) 13.3 (6/45) 13.8 (8/58) 15.0 (6/40) 0.333 
% Stunted (n) 15.7 (46/293) 20.8 (10/48) 20.5 (9/44) 15.5 (9/58) 13.3 (6/45) 13.8 (8/58) 10.0 (4/40) 
 
% Severely stunted (n) 1.0 (3/293) 0.0 (0/48) 0.0 (0/44) 1.7 (1/58) 0.0 (0/45) 0.0 (0/58) 5.0 (2/40) 
Median body mass index 
(interquartile range) 
16.1  
(14.8-17.3) 
14.8  
(13.2-16.3) 
N/A 
16.0  
(14.7-17.2) 
N/A 
16.2 
(15.2-17.5) 
N/A 0.652 
% Wasted (n)**** 11.8 (8/68) 0.0 (0/2) N/A 11.1 (4/36) N/A 13.3 (4/30) N/A 0.838 
HAEMATOLOGY 
Median hemoglobin in g 
dL-1 
(interquartile range)# 
12.0  
(11.4-12.7) 
12.0  
(11.4-12.6) 
12.2 
(11.4-12.8) 
11.8  
(11.2-12.4) 
12.1 
(11.3-12.8) 
12.3 
(11.5-13) 
12  
(11.5-12.5) 
0.274 
% Anemic (n)*****# 34.5 (86/249) 41.0 (16/39) 33.3 (12/36) 44 (22/50) 35.1 (13/37) 21.2 (11/52) 34.3 (12/35) 0.232 
IMMUNOCHEMICAL 
% Fecal occult blood test 
positive 
41.2 (61/148) 46.9 (15/32) 44.0 (11/25) 32.0 (8/25) 27.3 (6/22) 48.2 (13/27) 47.1 (8/17) 0.489 
PARASITOLOGY 
Schistosomiasis 
% S. mansoni infection 
by urine-CCA (n)~ 
80.5 (231/287) 82.6 (38/46) 75.0 (33/44) 87.7 (50/57) 79.1 (34/43) 79.0 (45/57) 77.5 (31/40) 0.663 
% Egg patent 
S. mansoni infection 
(n)~~ 
44.3 (127/288) 39.1 (18/46) 36.4 (16/44) 46.6 (27/58) 35.7 (15/42) 45.8 (27/59) 61.5 (24/39) 0.163 
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Mean epg (95% 
confidence interval))~~ 
449.5 
(330.1-568.9) 
215.2 
(108.1) 
568.6 
(156.2-981.1) 
430.4 
(170.9-690.0) 
505.8 
(202.6-809.1) 
505.8 
(202.6-809.1) 
656.3 
(284.5-1028.1) 
0.241 
S. mansoni intensity~~ 
 
% Negative (n) 55.9 (161/288) 60.9 (28/46) 63.6 (28/44) 53.5 (31/58) 64.3 (27/42) 54.2 (32/59) 38.5 (15/39) 
 
% Light (n) 10.1 (29/288) 4.4 (2/46) 9.1 (4/44) 13.8 (8/58) 7.1 (3/42) 10.2 (6/59) 15.4 (6/39) 
 
% Medium (n) 11.8 (34/288) 13.0 (6/46) 6.8 (3/44) 8.6 (5/58) 14.3 (6/42) 13.6 (8/59) 15.4 (6/39) 
 
% Heavy (n) 22.2 (64/288) 21.7 (10/46) 20.5 (9/44) 24.1 (14/58) 14.3 (6/42) 22.0 (13/59) 30.8 (12/39) 
 
Malaria 
% Malaria (n)^ 65.2 (122/187) 88.9 (24/27) 82.6 (19/23) 65.9 (29/44) 63.0 (17/27) 43.2 (16/37) 58.6 (17/29) 0.003 
% P. falciparum (n) 65.2 (122/187) 88.4 (24/27) 82.6 (19/23) 65.9 (29/44) 63.0 (17/27) 43.2 (16/37) 58.6 (17/29) 0.008 
% Mixed (n) 11.2 (21/187) 18.5 (5/27) 8.7 (2/23) 15.9 (7/44) 7.4 (2/27) 8.1 (3/37) 6.9 (2/29) 0.648 
Giardiasis 
% Giardia duodenalis 
infection (n)^^ 
21.4 (63/294) 14.9 (7/47) 14.9 (7/47) 18.6 (11/59) 25 (11/44) 23.3 (14/60) 35.1 (13/37) 0.193 
20m-SHUTTLE RUN TEST 
Median VO2max in  
mL kg-1 min-1  
(interquartile range) 
45.4 
(42.9-48.0) 
45.7 
(43.9-47.9) 
46.0 
(43.6-48.9) 
45.4 
(43.0-47.5) 
47.0 
(42.9-49.5) 
45.4 
(43.8-47.5) 
42.1 
(40.8-45.0) 
< 0.001 
Males 
47.5 
(43.9-49.0) 
47.5 
(45.5-49.2) 
48.4 
(45.9-50.4) 
46.3 
(44.8-49) 
48.0 
(46.4-50.0) 
47.25 
(43.8-49.7) 
43.2 
(41.7-46.4) 
0.005 
Females 
43.9 
(41.5-46.3) 
44.6 
(42.9-45.7) 
43.9 
(41.8-46) 
43.9 
(41.5-47.0) 
43.9 
(42.9-47.5) 
44.8 
(42.9-46.3) 
41.5 
(39.9-43.8) 
0.100 
 273 
*Indicates significance of differences among the villages by Kruskal-Wallis or Chi-squared analysis, paired T test or ANOVA. Statistically significant differences (P ≤ 0.05) 274 
indicated in bold. **As defined by height-for-age Z-scores ≤ 2 S.D. below mean.37 ***According to validated stunting charts based on height-for-age Z-score: 'stunted' (≤ 2 - > 3 275 
S.D. below mean), 'severely stunted' (≤ 3 S.D. below mean).36 ****As defined by BMI-for-age Z-scores ≤ 2 S.D. below mean.37 *****As per standardised hemoglobin cut-offs for 276 
age: < 11.5 g/dL (5 - 11y), < 12.0 g/dL (12 - 14y). #Hemoglobin adjusted for altitude. 40 ~As per urine-cathodic circulating antigen testing. ~~As per dual Kato-Katz examination. 277 
Intensity defined by epg: 1 - 99 = light; 100 - 399 = medium, ≥  400 = heavy.29 ^As per malaria rapid diagnostic testing. ^^As per Giardia/Cryptosporidium Quik Chek test.278 
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 280 
 281 
 282 
 283 
 284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
 293 
 294 
Figure 2. Comparison of mean VO2max between Ugandan (study), Kenyan & Canadian 295 
cohorts by gender & age (Canadian & Ugandan data sourced from Leger et al. & Bustinduy et 296 
al., respectively).2, 11 297 
 298 
Associations between Infection, Nutritional Status, & Aerobic Capacity 299 
Unadjusted and multivariable-adjusted analyses examining VO2max as an outcome 300 
were performed using linear regression. Covariates studied included S. mansoni egg patent 301 
infection, fecal occult blood, malaria and stunting (based on validated charts). The analyses 302 
were stratified by gender due to the differences in aerobic capacity between males and 303 
females (S3 Table), and by altitude for the purposes of this study. Model selection was 304 
performed using a stepwise procedure, followed by Akaike’s Information Criterion (AIC) as 305 
the model selection criterion. The model with the lowest AIC was selected. Tables 2 and 3 306 
and S4 Table summarize these findings.  307 
On unadjusted analysis, S. mansoni egg patent infection was a negative predictor of 308 
VO2max (Coeff -1.28, 95% CI -2.20 – 0.36, P = 0.007). Increasing S. mansoni intensity of 309 
infection correlated with decreasing VO2max (Coeff -0.496 95% CI -0.862 - -0.132, P < 310 
0.05). No other covariates demonstrated significant associations with VO2max. The 311 
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correlation between S. mansoni egg patent infection and VO2max remained when adjusted 312 
for the presence of fecal occult blood, malaria, stunting (based on validated charts), and 313 
anemia (Coeff -4.91, 95% CI -6.31 – 2.07, P < 0.001, Table 2). Similarly, for girls, S. 314 
mansoni egg patent infection was associated with VO2max on unadjusted (Coeff -1.91, 95% 315 
CI -3.12 - -0.70, P = 0.002) and multivariable-adjusted (Coeff -5.04, 95% CI -8.80 - -1.28, P 316 
= 0.011) analyses (S4 Table). For boys, no significant correlations with VO2max were 317 
identified. For schools residing at low altitudes, S. mansoni egg patent infection negatively 318 
correlated with VO2max on both unadjusted (Coeff -1.30, 95% CI -2.39 - -0.21, P = 0.02) 319 
and multivariable-adjusted (Coeff -3.96, 95% CI -6.56 - -1.368, P = 0.004) analyses. For 320 
schools residing at high altitude, malaria infection positively correlated with VO2max on both 321 
unadjusted (Coeff 2.83, 95% CI 0.49 – 5.17, P = 0.019) and multivariable-adjusted (Coeff 322 
5.52, 95% CI 0.08 – 10.96, P = 0.047) analyses (Table 3).  323 
 324 
Associations between Infection, Anemia, Fecal Occult Blood, & Nutritional Status 325 
Logistic regression was used to explore the association between fecal occult blood, 326 
anemia and stunting with infection status, with each covariate being recorded as 327 
dichotomous variables. S. mansoni egg patent infection positively correlated with fecal occult 328 
blood (OR 0.04, 95% CI 4.01 – 20.37, P < 0.05). S. mansoni egg patent infection was 329 
positively associated with anemia on unadjusted analysis (OR 1.85, 95% CI 1.08 – 3.15, P = 330 
0.02), as was fecal occult blood (OR 1.51, 95% CI 1.11 – 2.07, P = 0.01). Multivariable-331 
adjusted analysis revealed fecal occult blood to be the only positive predictor of anemia (OR 332 
1.96, 95% CI 1.11 – 3.43, P = 0.02, S6 Figure).   333 
Logistic regression was also used to analyse stunting (based on validated charts) as 334 
an outcome. S. mansoni egg patent infection positively correlated with stunting (OR 2.49, 335 
95% CI 1.30 - 4.77, P = 0.01) on unadjusted analysis, however this association did not 336 
remain when adjusted for the presence of fecal occult blood, malaria, and anemia (OR 0.75, 337 
95% CI 0.17 – 3.39, P = 0.71, S5 Table, S6 Figure).  338 
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TABLE 2: Linear Regression Models with VO2max as the Outcome. 339 
  Unadjusted Analysis Multivariable-adjusted Analysis 
 Coefficient 95% CI P Value Coefficient 95% CI P Value 
S. mansoni egg 
patent infection* 
-1.279 -2.199 -0.360 0.007 -4.191 -6.312 -2.070 < 0.001 
Fecal occult blood -1.181 -0.767 0.404 0.542 0.404 -0.533 1.342 0.392 
Malaria^ 0.142 -1.057 1.341 0.815 -0.811 -2.824 1.203 0.424 
Stunting~ -0.534 -1.650 0.583 0.348 -0.615 -2.934 1.704 0.598 
Anemia# -0.650 -1.663 0.363 0.208 0.364 -1.595 2.323 0.711 
 340 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 341 
malaria rapid diagnostic testing. ~According to validated stunting charts based on height-for-age Z-score ≤ 2 S.D. 342 
below mean.36 #As per standardised hemoglobin cut-offs for age: < 11.5 g dL-1 (5 - 11y), < 12.0 g dL-1 (12 - 14y). 343 
Hemoglobin adjusted for altitude.40 For multivariable-adjusted analysis: n = 68. P Value = 0.009. R-squared = 344 
0.2142. Adjusted R-squared = 0.1508. Akaike’s Information Criterion = 373.447. 345 
346 
TABLE 3: Linear Regression Models with VO2max as the Outcome, Stratified by Altitude. 347 
  Unadjusted Analysis Multivariable-adjusted Analysis 
 Coefficient 95% CI P Value Coefficient 95% CI P Value 
S. mansoni egg patent infection* 
Low altitude -1.299 -2.389 -0.208 0.020 -3.962 -6.556 -1.368 0.004 
High altitude -0.971 -2.712 0.770 0.271 0.452 -5.102 6.007 0.866 
Fecal occult blood 
Low altitude -0.610 -1.349 0.128 0.104 -0.226 -1.362 0.911 0.690 
High altitude 0.592 -0.333 1.518 0.205 0.694 -1.094 2.482 0.424 
Malaria^ 
Low altitude -0.938 -2.320 0.444 0.182 -2.121 -4.390 0.148 0.066 
High altitude 2.832 0.494 5.170 0.019 5.524 0.084 10.964 0.047 
Stunting~ 
Low altitude -0.448 -1.749 0.853 0.498 -0.126 -2.715 2.463 0.922 
High altitude -0.719 -2.875 1.438 0.510 -0.842 -6.230 4.547 0.746 
Anemia# 
Low altitude -0.924 -2.145 0.297 0.137 0.891 -1.418 3.201 0.440 
High altitude -0.326 -2.076 1.424 0.711 -1.834 -5.384 1.717 0.291 
 348 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 349 
malaria rapid diagnostic testing. ~According to validated stunting charts based on height-for-age Z-score ≤ 2 S.D. 350 
below mean.36 #As per standardised hemoglobin cut-offs for age: < 11.5 g dL-1  (5 - 11y), < 12.0 g dL-1 (12 - 14y). 351 
Hemoglobin adjusted for altitude.40 For multivariable-adjusted analysis: Low altitude: n = 45. P Value = 0.022. 352 
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R-squared = 0.277. Adjusted R-squared = 0.184. AIC = 246.900. High altitude: n = 23. P Value = 0.202. R-353 
squared = 0.326. Adjusted R-squared = 0.128. Akaike’s Information Criterion = 125.111.354 
 355 
Comparison between Baseline & Follow-up 356 
The prevalence of egg patent S. mansoni infection was similar at baseline and follow-357 
up (20.8% vs 25.0%, P = 0.053). Median hemoglobin was significantly higher at follow-up 358 
(10.7 g dL-1 vs 10.2 g dL-1, P < 0.001, Figure 2). Similarly, the prevalence of anemia was 359 
lower at follow-up (69.3% vs 72.9%, P = 0.001), particularly for those residing at low altitude. 360 
There was no difference in the prevalence of fecal occult blood between the two timepoints 361 
(22.9% vs 31%, P = 0.584, S2 Table). 362 
In those residing at low altitude, median VO2max declined between baseline and 363 
follow-up (47.0 mL kg-1 min-1 vs 48.7mL kg-1 min-1, P < 0.001), however remained similar 364 
between the two time-points in those residing at high altitude (46.3 mL kg-1 min-1 vs 46.3 mL 365 
kg-1 min-1, P = 0.349, S2 Table). Median VO2max was higher in those who had been treated 366 
two weeks prior at baseline, compared with those who were newly recruited to the study 367 
(46.3 mL kg-1 min-1, IQR 44.6 - 49.7 mL kg-1 min-1 vs 44 mL kg-1 min-1, IQR 42.1 - 47.5 mL 368 
kg-1 min-1, P < 0.001, Figure 3).  369 
 370 
 371 
 372 
 373 
 374 
 375 
 376 
 377 
Figure 3: (A) Median hemoglobin at baseline & follow-up. (B) Scatter plot of VO2max for 378 
follow-up & new participants with median & interquartile range.  379 
 380 
   (A)                                                           (B) 
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DISCUSSION 381 
Chronic childhood morbidity secondary to Schistosoma mansoni infection has been 382 
previously overshadowed by a lack of feasible morbidity metrics adaptable to the pediatric 383 
population living within resource-poor settings. This study has shown that S. mansoni egg 384 
patent infection is associated with decreased aerobic capacity in Ugandan schoolchildren, 385 
with lower aerobic capacities seen in Ugandan compared with Canadian children. The 386 
20mSRT proved to be a feasible and easily-implementable tool that may be harnessed for 387 
the identification of S. mansoni-related morbidity within the school setting. 388 
Negative correlations between all S. mansoni infection intensities and VO2max were 389 
found in our study, highlighting the important contribution of light intensity infections to S. 390 
mansoni-related morbidity.3, 4 These findings were based on the traditional Kato-Katz 391 
method which can miss up to 20-40% of active infections.41 However, in the presence of 392 
infections of moderate-high intensity as was predominantly the case in this study, both urine-393 
CCA and parasitological examination maintain high levels of accuracy.42  394 
The pathway between Schistosoma mansoni infection and decreased aerobic 395 
capacity is multifactorial and complex. Anemia is a known downstream effector of S. 396 
mansoni infection and has been shown to be associated with decreased aerobic capacity.2 397 
Fecal occult blood is a proxy marker of intestinal inflammation and mechanism for anemia in 398 
S. mansoni infection.27, 30, 43 S. mansoni egg patent infection and fecal occult blood both 399 
positively correlated with anemia in our study. Furthermore, S. mansoni egg patent infection 400 
was linked with stunting; another known pathway for anemia causation in S. mansoni 401 
infection.2 Figure 4 integrates the findings of this study with current knowledge to suggest a 402 
potential, albeit simplified, pathophysiological basis for reduced physical fitness in children 403 
living in S. mansoni-endemic areas.  404 
Previous studies have demonstrated a reduction in anemia, nutrition-related 405 
morbidity, fecal occult blood and increase in physical performance following praziquantel 406 
therapy.18, 24, 30, 34, 44, 45 A reassuring decline in the prevalence of anemia was noted in the 407 
follow-up cohort after treatment for schistosomiasis at baseline. Furthermore, higher aerobic 408 
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capacities were seen in those who had been recently treated, compared with those who 409 
were newly recruited to the study, emphasizing the reversibility of functional morbidities. It is 410 
important to note however that disentangling chronic morbidity and the effects of 411 
interventions in low resource settings is a challenging task. Chronic morbidity is confounded 412 
by polyparasitic infections, nutritional deficiencies and numerous other factors, such as 413 
socioeconomic status and food scarcity, which were unable to be accounted for within the 414 
constraints of this study.3, 4, 5, 46, 47  415 
 416 
 417 
Figure 4: Conceptual pathway for impaired physical fitness in S. mansoni infection in children. 418 
Note: broken arrows represent relationships described elsewhere. 419 
 420 
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Those children residing at high altitude exhibited higher aerobic capacities compared 421 
with those residing at low altitude. In the former, S. mansoni infection did not have a 422 
negative effect on aerobic capacity. With increasing altitude, barometric pressure and 423 
atmospheric partial pressure of oxygen decline, resulting in an increase in erythropoietin 424 
production. This occurs via the release of hypoxia inducible factor-alpha. Erythropoietin 425 
stimulates the bone marrow to increase iron turnover and production of nucleated red blood 426 
cells, thereby increasing red blood cell mass.48, 49, 50 These adaptations may transpire at 427 
altitudes as low as ~1000m.32 Such acclimatization may have dampened the deleterious 428 
effect of S. mansoni infection upon aerobic capacity in the children living at a higher altitude.  429 
This study has several limitations. The small sample size achievable within the time 430 
frame has limited the strength of the inferences one can make from the findings, particularly 431 
with regard to baseline and follow-up cohorts. Nevertheless, the sample size calculation 432 
performed at the outset was achieved, and these findings provide a robust indication for 433 
further investigation into the pathway linking S. mansoni infection with physical fitness in 434 
children living in S. mansoni-endemic areas. In addition, testing resource availability was 435 
limited due to the unforeseen need of the local clinic to use the resources for medical 436 
indications. No specific method for ensuring the children reached their maximal aerobic 437 
capacity was employed. Such methods are usually time-consuming and cumbersome and 438 
were therefore purposely avoided as a means of maintaining the external validity of the 439 
20mSRT as a school-based morbidity metric. The time period between baseline and follow-440 
up testing was brief, limiting the speculations one could make with regard to outcomes 441 
following previous exposure to infection and treatment. 442 
Areas requiring further investigation include: 1) the development of more rigorous 443 
diagnostic tests capable of detecting light infections and demonstrating antigenic cure, 444 
thereby illustrating treatment efficacy, 2) the innovation and application of feasible morbidity 445 
metrics with the ability to identify sequelae of S. mansoni infections of all intensities, 3) the 446 
degree of impact of various altitudes upon VO2max and interplay of these associations with 447 
parasitic infections and anemia, and 4) extended baseline-follow-up comparisons to 448 
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delineate the effects of treatment upon physical fitness within S. mansoni-endemic areas at 449 
different altitudes. 450 
This is the first study to document a relationship between S. mansoni infection and 451 
decreased aerobic capacity at high and low altitudes. Altitude acclimatization may be 452 
partially protective of this effect. Whilst the cause of impaired physical performance is 453 
multifactorial, this study provides evidence to support the important contribution that S. 454 
mansoni infection has toward childhood morbidity. The lower aerobic capacities seen in the 455 
Ugandan children compared with Kenyan and Canadian children emphasize the inherent 456 
need for morbidity assessment in children residing within S. mansoni-endemic areas. 457 
Furthermore, a recent malacological survey identified schistosomiasis transmission in 458 
regions with an altitude beyond 1400m, indicating the need for the geographical expansion 459 
of morbidity assessment.35, 51, 52 Widespread deployment of the 20mSRT throughout school 460 
settings represents a promising means by which schistosomiasis-related childhood morbidity 461 
may be rapidly detected and managed appropriately within these areas. 462 
 463 
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SUPPORTING INFORMATION 707 
 708 
S1 Table. Demographic, Hematologic, Immunochemical, Parasitological & 20m-Shuttle Run Test Findings in Villages of the Buliisa District at Low 709 
Altitude Compared with High Altitude. 710 
Parameter 
Total  
(n=304) 
Low Altitude  
(n=210) 
High Altitude 
(n=94) P Value* 
DEMOGRAPHY 
Median age in years (interquartile range) 11 (10-12) 11 (10-13) 11 (10-12) 0.876 
% Female (n) 49.7 (151/304) 50.0 (105/210) 48.9 (46/94) 0.864 
ANTHROPOMETRY 
Median height in centimeters (interquartile range) 134 (128.5-140.5) 135.5 (128.7-142.1) 133 (127.6-137.6) 0.046 
% Stunted by HFA Z-score (n)** 36.7 (79/215) 39.5 (60/152) 30.2 (19/63) 0.197 
% Stunted by validated charts (n)*** 16.7 (49/293) 16.5 (33/200) 17.2 (16/93) 0.450 
% Stunted (n) 15.7 (46/293) 15.0 (30/200) 17.2 (16/93) 
 % Severely stunted (n) 1.0 (3/293) 1.5 (3/200) 0.0 (0/93) 
Median body mass index (interquartile range) 16.1 (14.8-17.3) 16.1 (14.8-17.3) 14.8 (13.2-16.3) 0.435 
% Wasted (n)**** 11.8 (8/68) 12.1 (8/66) 0.0 (2/2) 0.600 
HAEMATOLOGY 
Median hemoglobin in g dL-1 
(interquartile range)# 
11.6  
(10.7-12.4) 
12.1 
(11.4-12.7) 
12.0 
(11.4-12.7) 
0.739 
% Anemic (n)#  34.5 (86/249) 33.0 (57/173) 38.2 (29/76) 0.426 
IMMUNOCHEMICAL 
% Fecal occult blood test positive (n) 41.2 (61/148) 42.6 (40/94) 38.9 (21/54) 0.654 
PARASITOLOGY 
Schistosomiasis 
% S. mansoni infection by urine-CCA (n)~ 80.5 (231/287) 80.3 (159/198) 80.9 (72/89) 0.906 
% Egg patent S. mansoni infection (n)~~ 44.3 (127/288) 47.0 (94/200) 37.5 (33/88) 0.135 
Mean epg (95% confidence interval) 449.5 (330.1-568.9) 527.2 (366.4-687.9) 273.1 (137.5-408.8) 0.133 
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S. mansoni intensity~~ 
 
% Negative (n) 55.9 (161/288) 53.0 (106/200) 62.5 (55/88) 
 
% Light (n) 10.1 (29/288) 12.0 (24/200) 5.7 (5/88) 
 
% Medium (n) 11.8 (34/288) 11.0 (22/200) 13.6 (12/88) 
 
% Heavy (n) 22.2 (64/288) 24.0 (48/200) 18.2 (16/88) 
 
Malaria 
% Malaria (n)^ 65.2 (122/187) 60.9 (81/133) 75.9 (41/54) 0.051 
% P. falciparum (n) 65.2 (122/187) 60.9 (81/133) 75.9 (41/54) 0.015 
% Mixed (n) 11.2 (21/187) 10.5 (14/133) 13.0 (7/54) 0.768 
Giardiasis 
 
% Giardia duodenalis infection (n)^^ 21.4 (63/294) 22.2 (45/203) 19.8 (18/91) 0.128 
20M-SHUTTLE RUN TEST         
Median VO2max in mL kg-1 min-1 (interquartile range) 45.4 (42.9-48.0) 44.8 (42.1-47.5) 46.3 (43.4-48.7) 0.031 
Males 47.5 (43.9-49.0) 46.4 (43.8-49.0) 47.9 (46.0-49.6) 0.078 
Females 43.9 (41.5-46.3) 43.9 (41.5-45.7) 44.3 (42.9-46.3) 0.258 
 711 
*Indicates significance of differences among the villages by Kruskal-Wallis or Chi-squared analysis, paired T test or ANOVA. Statistically significant differences (P ≤ 0.05) 712 
indicated in bold. **As defined by height-for-age Z-scores ≤ 2 S.D. below mean.37 ***According to validated stunting charts based on height-for-age Z-score: 'stunted' (≤ 2 - > 3 713 
S.D. below mean), 'severely stunted' (≤ 3 S.D. below mean).36 ****As defined by BMI-for-age Z-scores ≤2 S.D. below mean.37 #As per standardised hemoglobin cut-offs for 714 
age: < 11.5 g dL-1 (5 - 11y), < 12.0 g dL-1 (12 - 14y). Hemoglobin adjusted for altitude.40 ~As per urine-cathodic circulating antigen testing. ~~As per dual Kato-Katz 715 
examination. Intensity defined by epg: 1 - 99 = light; 100  -399 = medium, ≥ 400 = heavy.29 ^As per malaria rapid diagnostic testing. ^^As per Giardia/Cryptosporidium Quik 716 
Chek test. 717 
 718 
 719 
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S2 Table. Demographic, Hematologic, Anthropometric, Immunochemical, Parasitological & 720 
20m-Shuttle Run Test Findings in Baseline & Follow-up Cohorts. 721 
 722 
Parameter 
Baseline 
(n=96) 
Follow-up 
(n=96) P Value* 
DEMOGRAPHY 
Median age in years (interquartile range) 11 (9.5-12) 11 (9.5-12) 
 
Low altitude 11 (9-12) 11 (9-12) 
High altitude 11 (10-12) 11 (10-12) 
% Female (n) 51.0 (49/96) 51.0 (49/96) 
Low altitude 48.5 (16/33) 48.5 (16/33) 
High altitude 52.4 (33/63) 52.4 (33/63) 
HAEMATOLOGY 
Median hemoglobin in g dL-1, adjusted 
(interquartile range)# 
10.2 (9.6-11.7) 10.7 (9.7-12.1) <0.001 
Low altitude 11.8 (11.0-12.3) 12.5 (11.9-13.1) <0.001 
High altitude 11.5 (10.6-11.9) 112.0 (11.2-12.6) <0.001 
% Anemic, adjusted (n)# 47.9 (23/48) 69.3 (25/75) 0.001 
Low altitude 42.9 (9/21) 20.8 (5/24) 0.002 
High altitude 51.9 (14/27) 39.2 (20/51) 0.098 
IMMUNOCHEMICAL 
% Fecal occult blood test positive 22.9 (11/48) 31.0 (18/58) 0.584 
Low altitude 28.6 (6/21) 35.0 (7/20) 0.774 
High altitude 18.5 (5/27) 29.0 (11/38) 0.137 
PARASITOLOGY 
% S. mansoni infection by urine-CCA (n)~ 62.5 (30/48) 76.1 (67/88) <0.001 
Low altitude 57.1 (12/21) 69.0 (20/29) 0.005 
High altitude 66.7 (18/27) 79.7 (47/59) 0.001 
% Egg patent S. mansoni Infection (n)~~ 20.8 (10/48) 25.0 (22/88) 0.053 
Low altitude 28.6 (6/21) 17.2 (5/29) N/A 
High altitude 14.8 (4/27) 28.8 (17/59) 0.006 
Mean eggs per gram 
(95% confidence interval)~~ 
49.8 (-13.1-112.6) 251.5 (86.4-416.5) 0.375 
Low altitude 75.4 (-64.6-215.5) 344.7 (-41.6-731.0) 0.277 
High altitude 29.8 (-11.6-71.1) 205.6 (47.1-364.1) 0.663 
S. mansoni intensity~~  
% Negative (n) 79.2 (38/48) 75.0 (66/88) 
 
% Light (n) 14.6 (7/48) 5.7 (5/88) 
% Medium (n) 2.1 (1/48) 6.8 (6/88) 
% Heavy (n) 4.2 (2/48) 12.5 (11/88) 
Low Altitude 
% Negative (n) 71.4 (15/21) 82.8 (24/29) 
 % Light (n) 23.8 (5/21) 3.5 (1/29) 
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% Medium (n) 0.0 (0/21) 0.0 (0/29) 
% Heavy (n) 4.8 (1/21) 13.8 (4/29) 
High Altitude 
% Negative (n) 85.2 (23/27) 71.2 (42/59) 
 
% Light (n) 7.4 (2/27) 6.8 (4/59) 
% Medium (n) 3.7 (1/27) 10.2 (6/59) 
% Heavy (n) 3.7 (1/27) 11.9 (7/59) 
% Giardia duodenalis infection (n)^^ 20.8 (10/48) 14.9 (14/94) 1.000 
Low altitude 13.3 (3/21) 12.5 (4/32) 0.732 
High altitude 25.9 (7/27) 16.1 (10/62) 0.992 
20M SHUTTLE RUN TEST 
Median VO2max in mL kg-1 min-1 
(interquartile range) 
47.45 (45.4-50.3) 46.3 (43.9-49.1) 0.001 
Low altitude 48.7 (46.3-52.0) 47.0 (43.9-48.7) <0.001 
High altitude 46.3 (43.9-48.7) 46.3 (43.9-49.5) 0.349 
 723 
Associations determined by linear regression. *Indicates significance of differences among the villages by 724 
Kruskal-Wallis or Chi-squared analysis, paired T test or ANOVA. Statistically significant differences (P ≤ 0.05) 725 
indicated in bold. #As per standardised hemoglobin cut-offs for age: < 11.5 g dL-1 (5 - 11y), < 12.0 g dL-1 (12 - 726 
14y). Hemoglobin adjusted for altitude.40 ~As per urine-cathodic circulating antigen testing. ~~As per dual Kato-727 
Katz examination. Intensity defined by eggs per gram (epg): 1 - 99 = light; 100 - 399 = medium, ≥ 400 = heavy.29 728 
^^As per Giardia/Cryptosporidium Quik Chek test. 729 
 730 
 731 
 732 
 733 
 734 
 735 
 736 
 737 
 738 
 739 
 740 
 741 
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 743 
 744 
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 749 
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S3 Table. Comparison of Mean VO2max between Study Participants & Reference Canadian 751 
Cohort. 752 
 753 
Age Gender 
Canadian Cohort Study Cohort 
P Value 
n Mean VO2max (S.D.) n Mean VO2max (S.D.) 
7 
Male 297 51.23 (3.34) 2 46.30 (3.39) <0.001 
Female 299 50.26 (2.63) 1 N/A N/A 
8 
Male 303 51.67 (3.91) 9 44.66 (4.03) <0.001 
Female 308 49.82 (3.44) 14 42.33 (3.05) <0.001 
9 
Male 322 51.54 (4.39) 20 47.34 (4.28) <0.001 
Female 322 49.20 (3.24) 22 44.42 (2.77) <0.001 
10 
Male 404 51.64 (4.23) 30 47.32 (3.75) <0.001 
Female 335 46.84 (2.76) 28 44.53 (4.10) 0.006 
11 
Male 386 51.13 (4.53) 23 46.47 (3.65) <0.001 
Female 382 47.51 (4.04) 22 43.87 (4.18) <0.001 
12 
Male 341 51.92 (5.16) 29 46.95 (3.78) <0.001 
Female 292 46.65 (4.17) 29 44.72 (3.44) 0.005 
13 
Male 325 50.10 (5.21) 19 46.29 (3.51) <0.001 
Female 298 44.42 (4.76) 19 43.05 (4.03) 0.1568 
14 
Male 289 50.11 (5.20) 20 45.92 (3.86) <0.001 
Female 260 41.65 (4.72) 16 43.85 (3.57) 0.026 
15 
Male 333 50.20 (6.07) 1 48.80 (N/A) <0.001 
Female 260 41.16 (5.07) 1 41.50 (N/A) N/A 
 754 
Canadian data obtained from Leger et al., 1988. Differences determined by one-way T test. Statistically 755 
significant differences (P ≤ 0.05) indicated in bold. S.D. = Standard Deviation. 756 
 757 
 758 
 759 
 760 
 761 
 762 
 763 
 764 
 765 
 766 
 767 
 768 
 769 
 770 
 771 
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S4 Table. Linear Regression Models with VO2max as the Outcome, Stratified by Gender. 772 
  Unadjusted Analysis Multivariable-adjusted Analysis 
 Coefficient 95% CI P Value Coefficient 95% CI P Value 
S. mansoni egg patent infection* 
Males -0.842 -2.084 0.400 0.182 -2.407 -5.150 0.337 0.083 
Females -1.912 -3.123 -0.700 0.002 -5.038 -8.794 -1.283 0.011 
Fecal Occult Blood 
Males -0.077 -0.878 0.724 0.848 0.090 -1.233 1.412 0.891 
Females -0.442 -1.234 0.349 0.269 0.343 -0.988 1.673 0.601 
Malaria^ 
Males -0.493 -2.039 1.054 0.529 -0.877 -3.524 1.770 0.504 
Females 0.759 -0.942 2.460 0.378 -0.260 -3.592 3.071 0.874 
Stunting~ 
Males -0.229 -1.966 1.508 0.795 -0.366 -3.541 2.809 0.815 
Females -0.345 -1.678 0.987 0.609 -1.251 -4.586 2.085 0.448 
Anemia# 
Males 0.134 -1.261 1.529 0.849 1.731 1.000 4.462 0.205 
Females -1.264 -2.601 0.072 0.063 -0.311 -3.444 2.822 0.840 
 773 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 774 
malaria rapid diagnostic testing. ~According to validated stunting charts based on height-for-age Z-score ≤ 2 S.D. 775 
below mean.36 #As per standardised hemoglobin cut-offs for age: < 11.5 g dL-1 (5 - 11y), < 12.0 g dL-1 (12 - 14y). 776 
Hemoglobin adjusted for altitude.40 For multivariable-adjusted analysis: Males: n = 36. P Value = 0.257. R-777 
squared = 0.188. Adjusted R-squared = 0.053. AIC = 195.429. Females: n = 32. P Value = 0.052. R-squared = 778 
0.330. Adjusted R-squared = 0.201. AIC = 176.918.779 
Smith et al.                                                              S.mansoni and fitness in Ugandan children 
 
 34 
S5 Table. Linear Regression Models with Stunting (by validated charts) as the Outcome. 780 
 781 
  Unadjusted Analysis Multivariable-adjusted Analysis 
  Odds Ratio 95% CI P Value Odds Ratio 95% CI P Value 
S. mansoni egg patent infection* 2.491 1.302 4.771 0.006 0.752 0.167 3.390 0.711 
Fecal occult blood 1.292 0.867 1.927 0.208 1.215 0.623 2.369 0.568 
Malaria^ 0.651 0.307 1.382 0.264 0.681 0.181 2.560 0.570 
Anemia# 1.391 0.665 2.908 0.381 1.233 0.322 4.726 0.760 
 782 
Statistically significant differences (P ≤ 0.05) indicated in bold. *As per dual Kato-Katz examination. ^As per 783 
malaria rapid diagnostic testing. #As per standardised hemoglobin cut-offs for age: < 11.5 g dL-1 (5-11y), < 12.0 g 784 
dL-1  (12-14y). Hemoglobin adjusted for altitude.40 For multivariable-adjusted analysis: AIC = 73.21548. n = 70. P 785 
value = 0.92. Pseudo R-squared = 0.0144. likelihood ratio chi-squared test = 0.92. 786 
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S6 Figure. Adjusted Odds Ratios for Anemia (A) and Stunting (B; by validated charts).  830 
 831 
 832 
 833 
 834 
 835 
 836 
The final models were controlled for (a) S. mansoni egg patent infection, fecal occult blood, malaria and stunting 837 
(by validated charts), & (b) S. mansoni egg patent infection, fecal occult blood, malaria and anemia. *OR 1.96; 838 
95% CI 1.11 - 3.43, P = 0.020. 839 
 (A) (B) 
